{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["5"],"submitter":["Kestelyn E"],"pubmed_abstract":["<h4>Background</h4>The introduction of female-initiated drug-delivery methods, including vaginal rings, have proven to be a promising avenue to address sexually transmitted infections and unintended pregnancies, which disproportionally affects women and girls in sub-Saharan Africa. Efficient uptake of existing and new technologies such as vaginal rings requires in depth understanding of product adherence. This remains a major challenge as data on adherence to vaginal rings from African countries is limited. In this study, we explored adherence of contraceptive vaginal ring (NuvaRing®) use in Kigali, Rwanda using a mixed methods approach.<h4>Methods</h4>We collected quantitative and qualitative data at multiple time points from women participating in a clinical trial exploring the safety an"],"journal":["Frontiers in global women's health"],"pagination":["1278981"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11047128"],"repository":["biostudies-literature"],"pubmed_title":["High adherence to intermittent and continuous use of a contraceptive vaginal ring among women in a randomized controlled trial in Kigali, Rwanda."],"pmcid":["PMC11047128"],"pubmed_authors":["Agaba S","Uwineza M","Van Nuil JI","Uwingabire A","Delvaux T","Umulisa MM","Umutoni G","De Baetselier I","Crucitti T","Kestelyn E","van de Wijgert JHHM"],"additional_accession":[]},"is_claimable":false,"name":"High adherence to intermittent and continuous use of a contraceptive vaginal ring among women in a randomized controlled trial in Kigali, Rwanda.","description":"<h4>Background</h4>The introduction of female-initiated drug-delivery methods, including vaginal rings, have proven to be a promising avenue to address sexually transmitted infections and unintended pregnancies, which disproportionally affects women and girls in sub-Saharan Africa. Efficient uptake of existing and new technologies such as vaginal rings requires in depth understanding of product adherence. This remains a major challenge as data on adherence to vaginal rings from African countries is limited. In this study, we explored adherence of contraceptive vaginal ring (NuvaRing®) use in Kigali, Rwanda using a mixed methods approach.<h4>Methods</h4>We collected quantitative and qualitative data at multiple time points from women participating in a clinical trial exploring the safety an","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024","modification":"2026-07-15T04:41:56.128Z","creation":"2026-06-29T03:09:38.093Z"},"accession":"S-EPMC11047128","cross_references":{"pubmed":["38680542"],"doi":["10.3389/fgwh.2024.1278981"]}}